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The immune system, best known as the first line of defense against invading pathogens, is integral to tissue
development, homeostasis, and wound repair. In recent years, there has been a growing appreciation that
cellular and humoral components of the immune system also contribute to regeneration of damaged tissues,
including limbs, skeletal muscle, heart, and the nervous system. Here, we discuss key findings that implicate
inflammatory cells and their secreted factors in tissue replacement after injury via stem cells and other repar-
ative mechanisms. We highlight clinical conditions that are amenable to immune-mediated regeneration and
suggest immune targeting strategies for tissue regeneration.Introduction
For centuries, biologists have marveled at the ability of organ-
isms such as salamanders to regrow near perfect copies of
amputated body parts through a precisely orchestrated process
called epimorphic regeneration. Epimorphic regeneration occurs
via the formation of a blastema, a mass of undifferentiated and
differentiated cells containing a heterogeneous pool of progeni-
tor cells. Instead of forming a blastema, the few mammalian tis-
sues that are capable of regenerating, such as blood, skeletal
muscle, and epithelium, renew predominantly through stem
cells. However, stem-cell-based regeneration has not proven
broadly effective for most tissues plagued by degenerative pro-
cesses such as the heart and nervous system. Here, we suggest
that immune-mediated mechanisms of regeneration and repair
may complement existing stem cell therapies or may be a viable
alternative to using stem cells as a way to promote functional
regrowth of vital tissues.
Regenerative Capacity and the Development of a
Mammalian Immune System: An Inverse Relationship
After injury, immune cell activation is among the first responses
detectable at the site of damage (Figure 1A). Whether immune
activation results in tissue regeneration or scarring is determined
by a variety of factors including age, species, and the availability
of a stem or progenitor cell pool. Evolutionary and develop-
mental advances in the immune system have been inversely
correlated with the capacity to fully regenerate damaged tissues
(Figure 1B) (Fukazawa et al., 2009; Mescher and Neff, 2005;
Mescher et al., 2013). The more phylogenetically primitive uro-
dele amphibians (salamanders), the only vertebrates with the
ability to completely regenerate limbs as adults, have a ‘‘weak’’
immune response in terms of specificity, speed of onset, and
memory compared to their anuran amphibian (frog) relatives.
Selective pressure to seal wounds rapidly with impermeable
scars may have increased as vertebrates left aquatic environ-
ments and became homeothermic, driving evolution of a robust
inflammatory response and refined adaptive immune system
at the expense of epimorphic regeneration. Likewise, Xenopus
larvae, which start with an ancestral-like immune system, can
regenerate hindlimbs and tails. After the peak of metamor-
phosis, when the immune system matures into a highly evolved,
mammalian-like system, regenerative capacity is lost (King et al.,14 Cell Stem Cell 15, July 3, 2014 ª2014 Elsevier Inc.2012). In mammals, wounds penetrating the dermis undergo
scarring postnally. During fetal development, however, dermal
injuries regenerate in a distinct process of scarless wound heal-
ing (Table 1). A number of factors likely enable scarless healing
(Larson et al., 2010), including varied composition of the extra-
cellular matrix (ECM), intrinsic differences in fibroblasts, and
a transient inflammatory response characterized by significant
decreases in platelet aggregation, leukocyte infiltration, and
cytokine production. In-depth understanding of the unique im-
mune systems of fully regenerating organisms or developmental
stages may provide clues to therapeutic avenues to restore
damaged tissues in mammals.
Developmental and Homeostatic Functions of the
Immune System
The immune system is integral to the initial development of an or-
ganism as well as the continuous replacement of differentiated
cell types to maintain homeostasis (Figure 1A) (reviewed in
Pollard, 2009; Wynn et al., 2013). Branching morphogenesis
and remodeling in the kidney, pancreas, mammary gland, retina,
and vascular system are regulated by leukocytes and soluble in-
flammatory factors. Myeloid cells, for example, modulate vascu-
larity (Nucera et al., 2011) by mediating angiogenic branching
(Kubota et al., 2009) and anastomosis (Fantin et al., 2010).
Mice deficient in the primary regulator of mononuclear phago-
cyte production, colony-stimulating factor 1 (Csf1), or its recep-
tor Csf1R lack themajority of functional myeloid cells and display
numerous developmental abnormalities due to disrupted ECM
remodeling (Banaei-Bouchareb et al., 2004; Dai et al., 2002;
Rae et al., 2007). Branching morphogenesis in the mammary
gland depends on eosinophils and mast cells (Gouon-Evans
et al., 2000; Lilla and Werb, 2010), illustrating that numerous
immune cells coordinate development. Immune cells also influ-
ence morphogenesis by acting directly on mammary stem cells
(Gyorki et al., 2009) and phagocytizing both apoptotic and se-
nescent cell debris (Dai et al., 2002; Mun˜oz-Espı´n et al., 2013).
Microglia phagocytize synaptic debris and are essential for the
pruning of synapses during normal postnatal brain development
(Paolicelli et al., 2011). Synapse pruning in the developing retina
relies on complement proteins C1q and C3 to tag CNS synapses
for destruction (Stevens et al., 2007). Conversely, C1q and C3
are upregulated in retinal synapses during glaucoma, suggesting
Figure 1. The Influence of the Immune System on Development,
Homeostasis, and Disease
(A) During embryonic and postnatal development, the immune system regu-
lates processes such as branching morphogenesis, ductal formation, and
angiogenesis. Similar functions are maintained in some adult tissues to
maintain normal homeostasis. Injury or disease elicits an inflammatory
response that can either promote functional restoration of the tissue (regen-
eration) or a rapid healing response that may protect the organism at the
expense of preserving structure and function. Inflammation usually resolves in
the regenerative response while inflammation often persists in wound healing
and scar formation, ultimately impairing the normal function of the tissue.
(B) Inverse relationship between the capacity to regenerate and the strength
and intricacy of the immune system during development or evolution. The
threshold indicated on the graph conceptualizes the balance point at which the
proregenerative components of the immune response are maintained within
the context of a more advanced immune system. Identifying this threshold will
be a key step toward the development of regenerative therapies targeted at
immunity.
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motes CNS degenerative disease.
Gene expression profiling, lineage tracing, and geneticmodels
have been increasingly used to identify novel tissue-specific
subsets of immune cells that shape development and regenera-
tion (King et al., 2012; Wynn et al., 2013). The recent discoveries
discussed below begin to shed light on how these specialized or
polarized populations of immune cells may be integral to pro-
moting regeneration in mammalian tissues. The nature and effi-
ciency of the reactivation of developmental functions during
injury may be critical to the ability of an organism to completely
regenerate injured tissue or not (Figure 1A). In this review, we
focus on recent advances showing a proactive role of the im-
mune system and its response to injury as a central mediator
of tissue regeneration. By drawing from different systems, com-
mon mechanisms and themes occurring in injury and disease
that may be relevant to new therapeutic avenues are highlighted.
Immune Mechanisms of Tissue Regeneration
Mammals respond to organ damage through either compensa-
tory growth of the remaining tissue, by activating resident pre-
cursor cell proliferation, or by the formation of a scar. Successful
mammalian regeneration requires precise coordination of multi-
ple processes, which include scavenging cellular debris, prolifer-
ation and activation of progenitor cells, immune modulation,
angiogenesis, and innervation of the newly forming tissue. While
the involvement of immune cells in tissue repair has been appre-
ciated since Metchnikoff observed that macrophages play a
role in tissue repair in the late 1800s, recent advances highlight
new mechanisms that the immune system employs to regulate
regeneration.
Debris Clearance
Efficient clearance of cellular debris prevents the persistence
of potentially toxic or immunogenic material in the tissue envi-
ronment and also activates phagocytes to secrete immuno-
modulatory factors that perform downstream effector functions
(Figure 2). Recent findings indicate that defects in debris clear-
ance can prevent effective regeneration. Macrophages, the pro-
fessional phagocytes of the immune system, mount a polarized,
biphasic response to tissue injury. Macrophages and the mono-
cytes fromwhich they are derived exhibit considerable heteroge-
neity that is not yet fully understood. After conditioning by the
inflammatorymilieu including local growth factors and cytokines,
macrophages polarize into classically activated (M1) or alterna-
tively activated (M2) subtypes based on their markers, function,
and cytokine profiles (Gordon andMartinez, 2010). Typically, M1
cells produce high levels of proinflammatory cytokines and nitric
oxides that aid in host defense but can also damage healthy tis-
sue, while M2 macrophages mediate wound healing, tissue
repair, and the resolution of inflammation. However, M1 cells
can also play a positive role in tissue regeneration. In the heart
and skeletal muscle, early infiltration by M1 macrophages facili-
tates clearance of necrotic tissue (Arnold et al., 2007; Nahrendorf
et al., 2007), and disrupting macrophage polarization impairs
healing and regeneration, respectively (Perdiguero et al., 2011).
While macrophages influence multiple facets of muscle regener-
ation, it appears that in some instances, debris clearance
may supersede their roles in satellite cell proliferation, myofiber
growth, and endothelial cell activation. For example, Hif-1a,Cell Stem Cell 15, July 3, 2014 ª2014 Elsevier Inc. 15
Table 1. Summary of the Regenerative Capacity, Mechanisms, and Disease States of Representative Mammalian Tissues
Tissue
Debris
Clearance
Mechanism
Progenitor
Cell Pool
Immune-Derived
Stimuli
Polarization and
Heterogenity
Disease State
due to Failed
Regeneration Defect
Drugs
Targeting
Immunity
Skin
(dermis)
macrophages,
fibroblasts,
keratinocytes
fibroblasts,
endothelial cells
TGFb, EGF,
VEGF, IGF
early and late
macrophages
(similar to M1/M2)
full-thickness
wound scarring
in adults
excessive
inflammation;
decreased
migration;
collagen
accumulation
IFN-a, IFN-b,
IFN-g; steroids
Heart M1 or Ly6Chi
monocytes/
macrophages
resident
cardiomyocytes
n/a four pools of cardiac
macrophages;
sequential Ly6Chi,
Ly6Clo
myocardial
infarction;
heart failure
lack of
progenitors;
insufficient
immune
polarization
ACE inhibitors
Skeletal
muscle
macrophages
and FAPs
satellite cells Treg amphiregulin,
IL-6, IL-1b, TNFa,
IGF1, TGFb
muscle Treg; M1/M2 muscular
dystrophy
myofiber defect;
satellite cell
exhaustion;
chronic
inflammation
glucocorticoids
CNS
(myelination)
macrophages
and microglia
oligodendrocyte
progenitor cells
IGF1 M1/M2 multiple
sclerosis
impaired
clearance
of myelin
debris
anti-GM-CSF;
Pioglitazone
(PPARg agonist);
Glatiramer acetate
Liver Kupffer cell
and liver
macrophages
hepatocytes
and hepatic
progenitor cells
eosinophil IL-4;
Kupffer IL-6,
TNFa
inflammatory and
restorative
macrophages;
Th1, Th2, Th17
lymphocytes
chronic liver
disease
(viral, toxic,
autoimmune,
metabolic)
unresolved
fibrosis
TLR4, CCR2
inhibitors;
PPAR-a/b
agonists
Bone osteoclast monocyte
progenitor
Csf1 n/a osteopetrosis or
osteoperosis
lack of or
excessive
bone
resorption
IFN-g1b,
corticosteroid;
RANKL inhibitor
(mAb)
The process of regeneration is summarized for six different tissues, each with varying regenerative capacities: skin, heart, skeletal muscle, CNS, liver,
and bone. For each, steps that have the potential to be influenced by immunity are listed as well as the disease state and summary of immune-targeted
therapeutics.
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is dispensable in satellite cells during skeletal muscle regenera-
tion. Surprisingly, myeloid-specific deletion of Hif-1a leads to
decreased activation of Cox-2, decreased macrophage phago-
cytosis, and a subsequent delay in skeletal muscle regeneration
(Scheerer et al., 2013).
Perhaps the strongest link between immune-mediated debris
clearance and regenerative capacity has been documented in
the CNS and in demyelinating diseases (Figure 2). The sensitivity
of the CNS to debris clearance may be attributed to the
numerous inhibitory properties of myelin, the membrane sheath
that insulates axons, when deposited in damaged tissue. While
remyelination is robust in the CNS of young, healthy mice, their
ability to restore the myelin sheath declines with age or in dis-
ease. Clearance of myelin debris depends on macrophages
(Kotter et al., 2006) and recent data suggest that the decline in
efficient CNS regeneration is linked to the immune system. Spe-
cifically, parabiosis experiments indicate that young macro-
phages recruited as monocytes from the blood have a greater
capacity to efficiently clear myelin debris than old macrophages
do (Ruckh et al., 2012). Furthermore, chronic degenerative dis-
ease occurs when phagocytosis is compromised by loss-of-16 Cell Stem Cell 15, July 3, 2014 ª2014 Elsevier Inc.function mutations in microglial Triggering Receptor Expressed
On Myeloid Cells 2 (TREM2) or DAP12 (also known as TYRO
protein tyrosine kinase-binding protein), its transmembrane
adaptor and signaling molecule (Neumann and Takahashi,
2007). Conversely, transplantation of myeloid cells that overex-
press TREM2 into experimental autoimmune encephalomyelitis
(EAE) mice, a model of multiple sclerosis (MS), improved myelin
removal and facilitated regeneration of the spinal cord (Takaha-
shi et al., 2007). Given the inhibitory effects of myelin on
oligodendrocyte differentiation, these data suggest a model in
which augmenting the clearance of debris by immune cells can
enhance CNS regeneration through efficient remyelination.
Elegant genetic studies such as those in skeletal muscle injury
models, discussed below, are beginning to reveal the signifi-
cance of nonmacrophage cell types in debris clearance and
regeneration (Figure 2). For example, debris-clearing fibro/
adipocyte progenitors have recently been shown to be pivotal
mediators of skeletal muscle regeneration and are discussed in
greater detail below (Heredia et al., 2013). Whether varied types
of debris and their key phagocytic cell types can influence
regeneration in other tissues will be an important topic for future
investigation.
Figure 2. Debris Clearance as a
Coordinator of Regeneration
Debris clearance orchestrated by the immune
system is a key activator of subsequent steps
in regeneration, including progenitor cell activa-
tion, differentiation, and immune polarization. The
comparison shown between skeletal muscle and
the CNS highlights the key cell types and soluble
factors involved. After skeletal muscle injury, both
M1 macrophages (Mf) and fibro/adipocyte pro-
genitors (FAPs) clear cellular debris. FAP phago-
cytic activity depends on eosinophil derived IL-4;
in its absence, the progenitors differentiate into
fat, causing muscle dysfunction. Phagocytic M1
macrophages promote myoblast proliferation and
polarize to an M2 phenotype via AMPK-mediated
signaling. M2 polarization is required for appro-
priate myoblast differentiation. In the CNS, mature
neurons lack robust regenerative potential. How-
ever, remyelination occurs in young, healthy adults
by activation of oligodendrocyte progenitor cells
(OPCs). Activation of OPC proliferation depends
on efficient clearance of myelin debris, which
contains inhibitory factors, and macrophage-
derived soluble factors. Similar to that of myo-
blasts, the proliferation and recruitment of OPCs
depends onM1macrophages while differentiation
of OPCs and remyelination relies on M2 macro-
phage-secreted activin-A.
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Perhaps the most astonishing discoveries in immune-mediated
regeneration have been made in skeletal muscle, a well-studied
model for adult mammalian regeneration that employs activation
of satellite cells, the resident progenitors of themuscle. While the
importance of macrophages in skeletal muscle regeneration has
long been appreciated (Arnold et al., 2007), both eosinophils and
regulatory T cells (Tregs) have now been shown to be necessary
for activation of satellite cells, which give rise to newly formed
myofibers after injury (Burzyn et al., 2013; Heredia et al., 2013;
Wynn et al., 2013) (Figure 3A). Using a number of genetic models
to trace and delete soluble factors and their receptors in a cell-
type-specific fashion, Heredia et al. showed that IL-4-secreting
eosinophils mediate skeletal muscle regeneration by activating
fibro/adipocyte progenitors (FAPs) which, as mentioned previ-
ously, mediate necessary debris clearance. In the absence of
IL-4, FAPs do not clear debris and instead differentiate into adi-
pocytes, which contribute to muscle degeneration (Figure 2).
Tregs modulate the activity of not only lymphocytes but also other
immune cells such as macrophages, and thereby can indirectly
influence the regenerative process. However, genetic ablation
of Tregs has shown that muscle Tregs directly enhance satellite
cell activation and differentiation by secreting amphiregulin
(Burzyn et al., 2013) (Figure 3A).
Neurons do not efficiently regenerate in mammals and several
studies suggest that the inflammatory response to injury im-
pedes neurogenesis (Carpentier and Palmer, 2009; Ekdahl
et al., 2003; Monje et al., 2003). In the zebrafish brain, which
has the capacity to regenerate and replace neurogenic activity,
recent work shows that inflammation is necessary and suffi-
cient to initiate neurogenesis via progenitor cell activation. After
injury, microglial cells and other leukocytes activate radial glial
cell proliferation and neurogenesis by secreting LeukotrieneC4 (LTC4) (Kyritsis et al., 2012). Even in the absence of injury,
LTC4 alone increases proliferation of progenitor glial cells and
the production of newborn neurons. Furthermore, inflammation
alone initiated production of S100b, an EF-hand type Ca2+-
binding protein, by radial glia and activation of the Gata3 tran-
scription factor. These factors represent molecular switches
that could be potentially targeted to promote neuronal differen-
tiation and survival (Stella, 2012). Similarly, in rats, promoting
inflammation in the eye through injury or pharmacological treat-
ment can stimulate axon outgrowth in the normally nonregener-
ative retinal ganglion cell (RGC) axons of the primary visual
pathway (Leon et al., 2000; Yin et al., 2003). Recent evidence
suggests that in mice both neutrophils and macrophages are
major sources of oncomodulin (Ocm), a key soluble factor in
inflammation-induced regeneration, and are essential for neurite
outgrowth in the CNS (Kurimoto et al., 2013; Kwon et al., 2013;
Yin et al., 2006).
While the liver is a unique example of adult mammalian organ
regeneration, the capacity for regeneration is compromised in
chronic disease (Table 1). The presence of bipotent hepatic pro-
genitor cells (HPCs) that can be activated to regenerate both cell
types involved inbile synthesis, cholangiocytes, andhepatocytes
leaves awindowof therapeutic opportunity open. Recent studies
in mice and humans have shown that macrophages control
signaling pathways that regulate hepatic progenitor cell fate
(Boulter et al., 2012). By studying divergent disease patterns in
human samples and inhibiting Notch signaling in mouse models,
the authors showed that Notch is required for adult biliary spec-
ification during chronic liver injury. During hepatocyte regen-
eration, the Notch signaling pathway is repressed though the
ubiquitin ligase Numb such that the loss of Notch signalingmedi-
ates exit from a biliary fate and the acquisition of a hepatocyte
phenotype inHPCs. Furthermore, phagocytosis of hepatic debrisCell Stem Cell 15, July 3, 2014 ª2014 Elsevier Inc. 17
Figure 3. Immune Cell Polarization and
Heterogeneity Are Key Components of
Tissue Repair or Regeneration
(A) The regenerative capacity of skeletal muscle
is driven by satellite cell activation, proliferation,
and differentiation. M1 macrophages are early re-
sponders that secrete cytokines with proliferative
effects on myoblasts. The next phase of the
response involves myotube differentiation driven
by M2 macrophage-secreted IGF1 and TGFb.
Specialized muscle Treg cells influence all stages of
regeneration: early secretion of amphiregulin acti-
vates myoblast proliferation, while in subsequent
phases of regeneration, muscle Tregs are necessary
for myotube differentiation, M1 to M2 polarization,
and attenuation of excessive T lymphocyte re-
sponses.
(B) The adult mammalian heart, which lacks
regenerative capacity, contains different cardiac
macrophage subsets, with diverse functions,
developmental origins, and mechanisms of ho-
meostasis. The four populations, segregated by
expression levels of CCR2, Ly6C, and MHC class
II, perform different functions as indicated. Upon
injury such as a MI, a biphasic monocyte response
occurs to promote an initial inflammatory phase
followed by a reparative phase mediated by Ly6Chi
or Ly6Clo splenicmonocytes, respectively. The two
systems are linked by the ability of splenic Ly6Chi
monocytes to replenish all four subsets in phase I.
In the neonatal mouse heart, which can fully
regenerate after MI, there is also a biphasic splenic
monocyte response, though the characterization of
subsets of resident cardiac macrophages has yet
to be investigated. Interestingly, neonatal cardiac
macrophages differ from those of the adult in their
localization, abundance, and gene expression
profile after injury and are required for regeneration
by promoting angiogenesis. The regenerative
subtype in the neonate has yet to be defined.
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Numb-activated hepatocyte program. In kidney regeneration,
macrophage-derivedWnt7b is required for renal tubular epithelial
regeneration (Lin et al., 2010). Crosstalk between the immune
systemandprogenitor cell populationsmediated by criticalmod-
ulators of cell-to-cell signaling such as Notch and Wnt therefore18 Cell Stem Cell 15, July 3, 2014 ª2014 Elsevier Inc.seems to be a common regenerative
signaling pathway in different tissues.
The immune system also affects pro-
genitor and stem cells by creating the
appropriate microenvironment for their
development and function. The idea that
macrophages create a niche for newly
forming blood cells during erythropoi-
esis, one component of the robustly
regenerating hematopoietic system, was
suggested half a century ago with the
identification of erythroblastic islands (a
central macrophage surrounded by devel-
oping erythroblasts) in the bone marrow.
Only recently, in vivo studies using genetic
and chemical models of macrophage
depletion confirmed a supportive role for
macrophages during red blood cell devel-
opment and diseases affecting erythro-poiesis such as polycythemia vera (Chow et al., 2013; Ramos
et al., 2013). As noted in the introduction, ductal morphogenesis
in mammary gland development depends on immune cells.
Mammary stem/progenitor cells also rely on the continued pres-
ence of macrophages as evidenced by their diminished repopu-
lating activity in macrophage-deficient (Csf-1op/op) mice or after
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suggests that macrophages may constitute part of the normal
mammary stem/progenitor cell niche. While macrophages
are not required for intestinal development and normal crypt
morphology, injury-activated macrophages in the colonic
epithelial progenitor cell niche express a number of factors that
promote proliferation and survival of epithelial progenitors.
Furthermore, intestinal macrophages recruited to the site of
injury and activated by the microbiota in a TLR-dependent
manner support and promote proliferation of colonic epithelial
progenitors (Pull et al., 2005). Therefore, the immune system is
a crucial element for shaping the crypt progenitor cell niche in
the injured intestinal epithelium.
Immunomodulation and Immune Cell Heterogeneity
Appropriate spatial and temporal regulation of the immune
response to injury or disease determines the soluble factor milieu
and therefore the future fate of the tissue. Resolution of the
inflammatory response leads to regeneration or chronic inflam-
matory cell activation and soluble factor production perpetuates
tissue damage and hampers repair (Figure 1A). Commonly, a
temporal shift or polarization occurs in the immune response
that is typically driven by M1, or proinflammatory macrophages,
andM2, or anti-inflammatory and reparative macrophages. Both
arms of the immune response are required for repair inmany sys-
tems such as heart, skeletal muscle, and the CNS. If initial, proin-
flammatory signals are not controlled, for example, excessive
tissue damage can occur and block repair. Conversely, prema-
ture initiation of the anti-inflammatory program can also disrupt
efficient tissue healing; for example, skeletal muscle regenera-
tion is impaired when macrophages are prematurely skewed
by treatment with IL-10 or genetic loss of MKP-1 (Perdiguero
et al., 2011). Also, in both skeletal muscle regeneration and re-
myelination, M1 macrophages recruit and stimulate progenitor
proliferation while M2 macrophages mediate differentiation,
dispelling the common view that M1 macrophage responses
are overall bad while those of M2 are good.
A host of M1 or M2 soluble factors are implicated in skeletal
muscle regeneration. While M1 macrophages activate the
proliferative stage of myogenesis and satellite cell proliferation
through production of IL-6, TNFa, IL-1b, and G-CSF, IGF1 and
TGFb production byM2macrophages supportsmyogenic differ-
entiation and growth (Arnold et al., 2007; Lu et al., 2011; Saclier
et al., 2013) (Figure 3A). Furthermore, the impact of M1/M2
macrophage skewing on modulating the inflammatory response
and skeletal muscle regeneration has recently been highlighted
with the identification of a new regulator of M1/M2 balance
(Figure 3A). AMP-activated protein kinase (AMPK), which regu-
lates energy homeostasis by sensing ADP:ATP and AMP:ATP
ratios, mediates the switch in macrophage polarization from
M1 to M2 and is necessary for regeneration after skeletal muscle
injury (Mounier et al., 2013). In wild-type mice, the phagocytosis
of muscle debris triggers M1 macrophages to skew toward M2
(Figure 2). Mice with macrophages deficient in AMPK have
impaired skeletal muscle regeneration due to the inability of
AMPK-deficient macrophages to skew toward M2 after phago-
cytosis. While the lack of AMPK does not impede myoblast pro-
liferation in vivo or in vitro, myogenesis is impaired by a defect in
differentiation and myotube formation. The potential importance
of AMPK signaling in other cell types and the signal from M2macrophages that mediates myogenic differentiation and tissue
regeneration remain to be identified and may hold promise as
therapeutic targets for degenerative muscle diseases.
Dual roles of immune cells in regenerating tissue are an
emerging theme. In addition to their direct role in satellite cell
activation described above, Tregs are central immunomodulators
of skeletal muscle regeneration by controlling T cell numbers
and the biphasic, sequential recruitment of proinflammatory
and anti-inflammatory macrophages (Burzyn et al., 2013)
(Figure 3A). Oligodendrocyte differentiation efficiently forms
new myelin sheets around axons in young, healthy mammals.
Peripherally derived macrophages and resident microglia are
important for clearing debris but also have been recently shown
to directly drive remyelination by promoting oligodendrocyte dif-
ferentiation through secretion of activin-A (Figure 2). Importantly,
a switch from M1 to M2 polarization was critical for effective re-
myelination (Miron et al., 2013).
Another emerging theme is that tissue-specific varieties of leu-
kocytes and lymphocytes perform multiple functions beyond
their roles in the immune system that are instrumental for tissue
homeostasis and disease. In addition to the muscle Tregs
described previously, recent genetic fate-mapping and deletion
studies reveal four different cardiac macrophage populations,
the origins fromwhich they arise, and themechanisms thatmain-
tain macrophage homeostasis and expansion in response to
cardiac stress (Epelman et al., 2014) (Figure 3B). Not only do their
developmental origins differ, but also transcriptional profiling
and functional assays show that each of the four subsets,
tracked by expression of CCR2, Ly6C, and MHC class II, have
specialized functions. The resident cardiac macrophages that
were MHC-IIlo contribute to homeostasis by phagocytosis of
cardiomyocyte debris. Furthermore, cardiac stress led to upre-
gulation of inflammasome and IL-1b-related genes from mono-
cyte-derived macrophage subsets that were CCR2+. Finally,
themacrophages that expressed high levels of MHC-II efficiently
processed and presented antigen to T cells, suggesting a role in
immunosurveillance. These findings shed light on the paradox
raised by previous data that upon injury, blocking CCR2 can
be cardioprotective while depleting macrophages by other stra-
tegies further increases injury and hampers cardiac function
(Kaikita et al., 2004; van Amerongen et al., 2007). Together, these
data suggest that preserving resident cardiac macrophage
expansion via proliferation, while targeting peripheral monocyte
recruitment, might lead to improved myocardial recovery after
injury. This landmark study (Epelman et al., 2014) highlights the
need to further delineate phenotypic and functional differences
among immune cells within specific tissues during homeostasis
and after injury so that therapies can be developed to preserve
subsets that are cytoprotective while targeting the activation
or recruitment of immune cells, in a subset-specific way, that
contribute to damage. Furthermore, gene expression profiling
comparing cardiac macrophages to splenic and brain macro-
phages illustrates that in addition to heterogeneity within the
same organ, significant variation in resident macrophages from
tissue to tissue warrants consideration (Pinto et al., 2012).
Angiogenesis
The reestablishment of adequate blood flow to injured and newly
forming tissue is a key aspect of regeneration. Immune cells sup-
port developmental angiogenesis by secreting soluble factors,Cell Stem Cell 15, July 3, 2014 ª2014 Elsevier Inc. 19
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vasculature during the maturation process. In the developing
mouse retina, vessel remodeling is under the control of macro-
phages (Stefater et al., 2011) via expression of the Wnt ligands
Wnt5a and Wnt11, which enhance the expression of the VEGF
inhibitory receptor Flt1. Interestingly, genetic disruption of the
myeloid noncanonical Wnt pathway can enhance wound angio-
genesis and repair, suggesting that the same signaling pathway
found in the retinal vasculature could have therapeutic appli-
cations for modulating myeloid cell signaling to treat wounds
(Stefater et al., 2013).
The wound healing response in adult mice and humans relies
on immune cells for secreting proangiogenic factors. Interest-
ingly, skin wounds in macrophage-deficient PU.1–/– mice heal
normally and show minimal scar formation (Martin et al., 2003).
However, temporal deletion of the myeloid lineage through diph-
theria-toxin-mediated cell death reveals that macrophages have
distinct functions in different phases of skin wound repair. When
deleted early, the loss of proinflammatory macrophages mini-
mized scar formation due to reduced keratinocyte cell death
and other damage, while later deletion resulted in hemorrhage
and lack of closure due to defects in angiogenesis, vascular
maturation, and stabilization (Lucas et al., 2010). Similar condi-
tional depletion of myeloid cells in a model of sciatic nerve injury
resulted in a decrease in vascular density and delayed neural cell
proliferation, implicating the immune system in the regenerative
angiogenesis of neural tissue (Barrette et al., 2008).
The adult mammalian heart is notoriously resistant to regener-
ation after injury, due primarily to the irreversible withdrawal
of postnatal cardiomyocytes from the cell cycle. After injury of
the adult heart, the inflammatory response and specifically the
monocyte/macrophage response has a dual function in scar
formation. During the later phase, Ly6Clo and M2 macrophages
are necessary for mediating angiogenesis concomitantly with
fibrosis to form a scar (Nahrendorf et al., 2007). In contrast,
before postnatal day (P) 7, neonatal mice efficiently regenerate
up to 20% of the mass of the heart after surgical ablation or
myocardial infarction (Porrello et al., 2011, 2013). Recent studies
showed that the immune response to cardiac injury differs quan-
titatively and qualitatively during regeneration in comparison
to the profibrotic response mentioned (Aurora et al., 2014).
Also, depletion of macrophages in P1mice subjected tomyocar-
dial infarction impaired heart regeneration, at least in part, due to
a lack of neoangiogenesis (Figure 3B). Given that the neonatal
mouse does not mount a robust fibrotic response after ischemic
cardiac injury, the data suggest that in mammalian heart regen-
eration, macrophages have the potential to promote angiogen-
esis without activating fibroblasts. The relative distribution in
the neonate of the four cardiac macrophage populations found
in the adult and the potential contribution of each population to
the process of neonatal heart regeneration and angiogenesis
remain to be defined (Figure 3B). The unique gene expression
profile of early neonatal macrophages is of future interest for
developing therapies that target the immune system to promote
angiogenesis and tissue regeneration.
Adult teleost fish, such as zebrafish, are highly regenerative
and equipped to regrow fins, retinae, spinal cord, and heart mus-
cle after amputation or injury. Zebrafish cardiomyocytes are
small andmononucleated and have underdeveloped sarcomeric20 Cell Stem Cell 15, July 3, 2014 ª2014 Elsevier Inc.structure, similar to embryonic and early postnatal cardiomyo-
cytes, and their proliferative capacity is integral to the heart’s
regenerative capacity. In both zebrafish and neonatal mice, the
regeneratedmyocardium is derived from preexisting cardiomyo-
cytes (Jopling et al., 2010; Kikuchi et al., 2010). The epicardium
provides progenitors important for angiogenesis during embry-
onic development and injury-induced heart repair or regenera-
tion in both organisms (Bock-Marquette et al., 2009; Kikuchi
et al., 2011; Smart et al., 2010) and recently has also been shown
to regulate the inflammatory response and neutrophil infiltration
after injury (Huang et al., 2012). Thymosin b4 (Tb4) is a key
activator of the epicardial progenitors that participate in neovas-
cularization, and its natural derivative b4-sulfoxide (Tb4-SO)
functions to prevent chronic inflammation and promote
wound healing (Evans et al., 2013), further suggesting a link be-
tween regulation of the immune response and regenerative
angiogenesis.
Regenerating skeletal muscle also relies on monocytes/
macrophages for neoangiogenesis. Sterile injury models using
transgenic lineage tracing of endothelial progenitors have shown
that macrophage depletion compromises the differentiation of
endothelial progenitors through the secretion of growth factors
(Zordan et al., 2014). In place of compromised progenitor differ-
entiation and angiogenesis, collagen accumulates and the
injured muscle becomes fibrotic.
Finally, ischemic disorders of the CNS, such as retinopathies,
are strongly associated with deficient or aberrant angiogenesis.
Recent studies in an ischemic retinopathy model show that ER
stress in ischemic neurons leads to downregulation of netrin-1,
which suppresses vascular regeneration in the hypoxic
CNS. Neuronal netrin-1 triggers an angiogenic switch in macro-
phages. Depleting retinal macrophages or antibody-mediated
blockade of VEGF hinders vascular regeneration, suggesting
that neuronal-derived netrin-1 is a potent mediator of myeloid-
cell-induced CNS vascular regeneration (Binet et al., 2013).
The significance of immune regulation of angiogenesis, pro-
genitor cell activity, debris removal, and appropriate polarization
of subsequent immune responses and soluble factor secretion
suggests that a closer look at proregenerative therapeutics
targeted at immunity is warranted. Below, we discuss some
of the diseases that lend themselves to such therapies and
examine potential ways to harness the immune system to pro-
mote regeneration.
Clinical Perspectives and Challenges
Disorders Susceptible to Regenerative Immunity
Multiple Sclerosis. MS is an autoimmune disease caused by in-
flammatory damage to the myelin sheath that protects the nerve
cells, leading to progressive degeneration of the demyelinated
neurons (Table 1). Research has largely focused on therapies
that could replace the myelinating cells, called oligodendro-
cytes, which derive from neural stem cells or further restricted
cells called oligodendrocyte progenitor cells. Inflammation plays
a complex role in the disease course of MS. While inflammation
had been generally thought to inhibit regeneration in the CNS,
several recent studies suggest that promoting inflammation
acutely, for example with zymosan injection, can stimulate oligo-
dendrocyte production (Foote and Blakemore, 2005; Setzu
et al., 2006). The positive influence of acute inflammation on
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showing that inflammation was sufficient for regeneration (Kyrit-
sis et al., 2012). How these effects manifest during the chronic
and oligodendrocyte-specific inflammatory response of MS re-
mains to be investigated further. It appears that shifting or
changing the polarization of the inflammatory response may
represent an alternative approach to simply blocking or inducing
inflammation in the context of demyelinating disease. As an
example, the recent findings showing that activin-A, solely ex-
pressed from M2 macrophages, can support remyelination
(Miron et al., 2013) suggests that immunomodulatory therapies
that induce an M2 macrophage shift may be candidates for clin-
ical use in MS (Weber et al., 2007).
Muscular Dystrophy. Muscular dystrophies refer to a group
of muscle wasting diseases characterized by progressive skel-
etal muscle weakness, defects in muscle proteins, and the death
of muscle cells and tissues. Despite the ability of skeletal muscle
to regenerate from satellite cells, necrosis of myofibers persists
in the context of inflammation and changes in the muscle envi-
ronment that eventually weaken the muscle system and hamper
function (Table 1).
The immune system plays a pivotal but complex role in the
pathogenesis of muscular dystrophies. Through their synthesis
of TGFb, macrophages in MDX mice, the mouse model for Du-
chenne’s muscular dystrophy, directly induce collagen produc-
tion in fibroblasts and further amplify collagen accumulation
through activation of profibrotic alternatively activated macro-
phages (Vidal et al., 2008). Furthermore, treating MDX mice
with a peptide that blocks the interaction between leukocyte-ex-
pressed integrin aMb2 and fibrinogen dampens muscle inflam-
mation and ameliorates disease. Myeloid cell infiltration and its
temporal shift from M1 to M2 are essential to regeneration, but
recent discoveries highlight the significance of other cell types
like Tregs and eosinophils (Burzyn et al., 2013; Heredia et al.,
2013). Not only do they modulate polarization of the immune
response, but they also have autonomous effects on satellite
cell and progenitor cell differentiation, respectively. Given that
glucocorticoids are currently the only therapy for muscular dys-
trophy, treatment of this disease may benefit from the develop-
ment of specific immunomodulatory therapies directed at Tregs
and/or eosinophils or the soluble factors they produce.
Heart Failure. A myocardial infarction (MI) occurs every 25 s in
the United States and often leads to heart failure, the leading
cause of death in the developedworld (Minin˜o et al., 2011). Given
that the adult mammalian heart lacks the inherent ability to
regenerate, ischemic loss of tissue is accompanied by replace-
ment of myocytes with a fibrous, noncontractile scar tissue
that compromises cardiac function and ultimately leads to heart
failure. Although some studies suggest that mammalian cardio-
myocytes have measurable capacity for turnover (reviewed in
Porrello and Olson, 2010), the presence of a true cardiac stem
cell is controversial and the response of the heart is not sufficient
to recover functional myocardium after significant cellular loss.
Failure of several stem cell therapies suggests that providing
progenitors may not be adequate and that approaches aimed
at the immune responsemay be required (Santini and Rosenthal,
2012). Furthermore, while a general wound healing response oc-
curs, complete with an inflammatory reaction, no therapeutic
measures have been developed tomodulate the immune systemto prevent heart failure. Starting more than 30 years ago, clinical
trials aimed at everything from a general block of inflammation to
more targeted approaches such as anti-CD18 integrin and com-
plement inhibition have had detrimental or little effect, respec-
tively, on outcomes after MI (reviewed in Frangogiannis, 2012).
Experimental models of MI and data from patients suggests
that while an inflammatory response is required for infarct heal-
ing, defects in resolution and containment of the response result
in adverse remodeling of the infarcted heart (Table 1). A number
of recent advances in understanding the immune response to
MI, in particular monocytes and macrophages, suggest that
the heart harbors a unique spectrum of myeloid cells and elicits
specialized immune responses in response to injury (Figure 3B).
Greater understanding of the monocyte subsets and the kinetics
by which they are recruited to the injured heart (Nahrendorf et al.,
2007) has led to a number of additional studies that are
increasing our understanding of how current therapies might
affect cardiac immunity. For example, angiotensin-converting-
enzyme (ACE) inhibitors, a standard treatment for MI and heart
failure, may be beneficial to infarct healing by having anti-
inflammatory properties and influencing specific monocyte
migration to the heart (Leuschner et al., 2010). Furthermore,
Ly6Chi monocytes recruited in the initial inflammatory phase
of the response to MI also dictate the reparative phase by differ-
entiating into Ly6Clo macrophages (Figure 3B) (Hilgendorf et al.,
2014).
In spite of these advancements, the focus of therapeutic stra-
tegies has been to stop uncontrolled or prolonged inflammation
in order to prevent adverse remodeling and progression to heart
failure. Studies have yet to shift to promoting specific compo-
nents of immunity to stimulate regeneration of the myocardium
instead of modulating scar formation. Until recently, the concept
of mammalian heart regeneration was not tractable due to lack of
in vivomodels. The capacity for neonatal mice to regenerate their
hearts depends on a unique population of macrophages, sug-
gesting a therapeutic opportunity may exist to promote heart
regeneration by modulating the immune response either alone
or in combination with therapies that stimulate cardiomyocyte
proliferation. Lessons from skeletal muscle and remyelination
suggest that efficient debris clearance is key to successful
regeneration by both eliminating inhibitory factors from the tis-
sue milieu and by triggering signaling cascades in phagocytes
that are necessary for downstream soluble factor release or
effector functions that promote regeneration. Careful genetic
dissection of the key regulators of debris clearance and the con-
sequences of cardiac injury may provide molecular targets for
new therapies.
Liver Fibrosis. The liver continues to be a unique example
of adult mammalian solid organ regeneration. However, chronic
liver disease, caused by viral infection, autoimmunity, toxic
injury, or steatosis, remains a major cause of morbidity and mor-
tality worldwide (Table 1). Recent efforts have uncovered
opposing roles for the immune system in controlling regeneration
during chronic liver disease. Proinflammatory Kupffer cells
and infiltrating macrophages initiate and promote fibrosis by
stimulation of stellate cells. In contrast, M2-like restorative mac-
rophages and NK cells drive the resolution of fibrosis by inducing
stellate apoptosis and senescence and also provide Wnt
signals to drive hepatocyte regeneration (Boulter et al., 2012;Cell Stem Cell 15, July 3, 2014 ª2014 Elsevier Inc. 21
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rophages protect the liver during schistosomiasis, not by battling
the infection, but by suppressing liver fibrosis and chronic
inflammation (Pesce et al., 2009). Current therapies focus on de-
terring fibrosis by dampening inflammation and fibroblast activa-
tion but have yet to enhance the positive, M2-like cells.
The underlying mechanisms of degenerating diseases in the
heart, CNS, skeletal muscle, or other organs clearly differ by
the presence or absence of a functional progenitor cell popula-
tion that has the capacity to repopulate the damaged tissue.
However, whether the regenerative strategy is to stimulate
endogenous progenitors, reprogram other cell types to replenish
the tissue, or to transplant exogenous cells, the native inhibition
of these processes that is present within the diseased tissue will
have to be appropriately modulated. The research highlighted
here suggests that understanding and having the tools to fine-
tune inflammation will be key to promoting a permissive environ-
ment for regeneration.
Inflammation: Harnessing the Good and Halting the Bad
Within minutes of injury, infiltrating neutrophils and other inflam-
matory cells release reactive molecules that can further damage
the tissue. Furthermore, chronic inflammation perpetuates tissue
remodeling and functional impairment in a number of diseases.
As a consequence, drug development and therapy has histori-
cally emphasized anti-inflammatories by way of steroids,
NSAIDS, and even more targeted approaches such as anti-
TNF monoclonal antibodies. The studies we highlight suggest
that new developments require a more fine-tuned approach
that allows specific blockade of the negative effects of inflamma-
tion in an environment that is permissive for the positive effects of
the immune response. Systematic dissection of these compo-
nents will aid in defining the threshold for which immunity is
strong but regeneration is permitted (Figure 1B) and allow pre-
cise therapeutic modulation to promote regeneration.
One emerging theme is to modulate the polarization of the
immune response, and recent data suggest that modulating
the port of entry for inflammatory cells may be one strategy.
Similar to repair of the heart or skeletal muscle (Arnold et al.,
2007; Nahrendorf et al., 2007), recovery from spinal cord injury
requires a biphasic monocyte/macrophage response, in which
M1 and M2 cells enter the injured tissue through distinct routes
(Shechter et al., 2013). M1 macrophages penetrate the injured
spinal cord through the leptomeninges while the cerebrospinal-
fluid filled choroid plexus provides a permissive environment
for M2macrophages to repair the spinal cord. These results sug-
gest that therapeutic modulation at distinct ports of entry to the
injured CNS could be a novel approach to promote repair and
regeneration.
Scrutiny of the immune responses in animal models of efficient
regeneration will be essential for clues to therapeutically modu-
late the disease environment. Recent studies showed direct
evidence for immunological control of complete regeneration in
the adult vertebrate and neonatal mammal. Axolotls, aquatic
salamanders, deploy a rapid and robust inflammatory response
in the amputated limb that includes nearly immediate and early
upregulation of anti-inflammatory cytokines and macrophage
dynamics. Systemic macrophage depletion of macrophages
blocks axolotl limb regeneration, which can be restored upon
reamputation and replenishment of the macrophage population22 Cell Stem Cell 15, July 3, 2014 ª2014 Elsevier Inc.(Godwin et al., 2013). This dynamic and simultaneous induction
of inflammatory processes in regenerating axolotl limbs is remi-
niscent of the rapid and concurrent fibroblast activity and cyto-
kine secretion noted during scarless wound healing in the
mammalian fetus (Larson et al., 2010). In addition, macrophages
are necessary for heart regeneration in the neonatal mouse
(Aurora et al., 2014).
The development of treatments targeting the immune system
is currently hindered by the lack of markers to discriminate
among subpopulations of immune cells, creating a gap in our un-
derstanding of how various subsets behave in normal and
diseased tissues. An additional strategy to identify novel immu-
nomodulatory targets for regenerative therapies is to thoroughly
dissect the diversity and function of resident tissue-specific im-
mune cells under conditions of homeostasis and injury, similar to
the methodology used in the recent discovery of four cardiac
macrophage subsets discussed above (Figure 3B) (Epelman
et al., 2014). Therapies targeted at individual immune cell popu-
lations or soluble factors are being tested, though they primarily
aim to curtail inflammation and affiliated fibrosis. Small mole-
cules or monoclonal antibody inhibitors to Csf1R target macro-
phages by blocking its ligand, ligand binding, or activation
signaling (Patel and Player, 2009). While targeting inflammation
alone could be sufficient to promote regeneration, a more plau-
sible scenario will involve the creation of an immunologically
permissive environment in the context of other regenerative ther-
apies. As an example, a recent study showed that acinar cell to
beta-like cell conversion occurs in response to treatment with
cytokines (Baeyens et al., 2014). In addition, recent findings sug-
gest that efficient iPSC formation depends on chromatin remod-
eling changes that are mediated by TLR signaling (Lee et al.,
2012).
Evolution clearly selected fast healing and containment of
injury or infection at the expense of the ability to reform a
completely functional tissue. In order to selectively undo the
loss of regenerative capacity without compromising the speci-
ficity and strength of the mammalian immune system, much re-
mains to be learned about the functions of immunity, good and
bad, in development, homeostasis, and injury. The recent ad-
vances highlighted here improve our understanding of the cells
and signals involved and underscore the potential of immuno-
therapies for tissue regeneration.ACKNOWLEDGMENTS
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